NN 5492Alternative Names: MAS; NNC 54-0092
Latest Information Update: 16 Oct 2006
At a glance
- Originator Novo Nordisk
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Female infertility
Most Recent Events
- 27 Sep 2002 This agent is still in active development
- 14 Apr 1999 Preclinical development for Female infertility in Denmark (Unknown route)